Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance.
about
Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertensionAntihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Influence of West African Ethnicity and Gender on Beta-Cell Function and Insulin Sensitivity in Essential Hypertensives Treated with Hydrochlorothiazide and Hydrochlorothiazide-lisinopril Combination.Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseA randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.Should we quantify insulin resistance in patients with renal disease?Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle.Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes.Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.B-type natriuretic peptide levels and insulin resistance in patients with severe ischemic myocardial dysfunction.Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
P2860
Q28301752-2B0F3C44-F0FE-4DAF-A089-8482196EDCA8Q33561456-2B50522E-6F74-471D-9562-00C12C4B5088Q33872249-1805D3E4-BF56-445C-8634-23B1752386CBQ35027981-5845A0AC-7E13-4434-A42E-BE200D160F8FQ35072984-8C4380F7-0E96-426B-BC66-E4EDD59D8A00Q35106848-506404E6-4399-4B74-BEAF-D1F3015B3AD0Q35453763-739FA3E4-48DE-4980-9D4B-C1D5539A8417Q35744489-C1A879E1-4289-4FE0-B388-DBC84E7DE23CQ36341789-80EC6B80-E336-47AC-A224-DB0FCC417F16Q36736724-89E08178-8FE4-49B0-A31E-1882D08150FEQ36854401-AD0F134F-2C9C-44A5-847D-26CECF09955FQ37039767-FD733B82-E13C-42D9-B362-4FB43F129023Q37076468-73A2C461-303F-45F9-8784-DC8B5C015ACFQ37132930-B35E0021-3696-48DC-BF24-7CDABA062DF4Q37161863-E3FA2369-EDB0-438C-AA5A-54CE9CED3877Q37201619-043EA081-53C5-40DD-BF02-5EC1ECCC98E5Q37202153-0C5AD9F6-4262-448A-90C4-0B8953DE0A63Q37626852-D6F9EF25-224A-49C8-9619-BFBB32535B11Q37629831-4CED4AAE-A2BE-4AA9-A299-715EBCF4C6B0Q37950397-F0D4D840-37E4-4D29-87A3-A373EDEFBC5AQ45997350-08F56B0A-972D-4735-B202-5A9A22034C45Q46918162-9F0CC315-1A71-4867-8EAD-EB3788297A7B
P2860
Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@ast
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@en
type
label
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@ast
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@en
prefLabel
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@ast
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@en
P2860
P1476
Angiotensin converting enzyme ...... tal muscle insulin resistance.
@en
P2093
P2860
P304
P356
10.1046/J.1463-1326.2003.00265.X
P577
2003-07-01T00:00:00Z